| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 17 |
| 1 | OLMESARTAN MEDOXOMIL | 15 |
| 2 | AZATHIOPRINE | 11 |
| 3 | INFLIXIMAB | 10 |
| 4 | TACROLIMUS | 10 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 10 |
| 6 | TACROLIMUS OINTMENT 0.1% | 10 |
| 7 | BUDESONIDE | 9 |
| 8 | VEDOLIZUMAB | 9 |
| 9 | ACETAMINOPHEN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCERIN SUPPOSITORY | 6 | 0.0023 |
| 1 | GLYCERIN SUPPOSITORIES | 6 | 0.0022 |
| 2 | SONIDEGIB | 1 | 0.0006 |
| 3 | CILTACABTAGENE AUTOLEUCEL | 3 | 0.0005 |
| 4 | OLMESARTAN MEDOXOMIL | 15 | 0.0004 |
| 5 | TREOSULFAN | 1 | 0.0004 |
| 6 | DANAZOL | 1 | 0.0004 |
| 7 | TREMELIMUMAB | 1 | 0.0002 |
| 8 | HUMAN IMMUNOGLOBULIN G | 4 | 0.0002 |
| 9 | BUSULFAN | 3 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Non-Standardized Plant Allergenic Extract [EPC] | 6 | 0.0003 |
| 1 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 4 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 11 | 0.0001 |
| 6 | Integrin Receptor Antagonist [EPC] | 9 | 0.0001 |
| 7 | Non-Standardized Chemical Allergen [EPC] | 6 | 0.0001 |
| 8 | Arteriolar Vasodilator [EPC] | 6 | 0.0001 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |